|
|
|
 |
FDA Approval Activities for this Drug…
Banan (cefpodoxime proxetil) Tablets and Suspension Sankyo Pharma NDA: 50-687/SE8-004, SE1-007, SE2-010, SE2-011 NDA: 50-688/SE8-006, SE1-008, SE2-011, SE2-012 Cefpodoxime Proxetil Tablets, Ranbaxy Limited ANDA 65-083 8/20/03 Cefpodoxime Proxetil Powder Suspension, Ranbaxy Limited ANDA 65-082 Vantin (cefpodoxime proxetil) Suspension, 5 mg/kg Pharmacia & Upjohn NDA 50-675/S-014 11/20/98 11/20/98 8/1/01 Vantin (cefpodoxime proxetil) Tablets and Vantin® (cefpodoxime proxetil) Suspension. Pharmacia & Upjohn NDA 50-674/S-012 50-675/S-015 CEFPODOXIME PROXETIL For Suspension; 100MG BASE/5ML VANTIN PHARMACIA AND UPJOHN 050675 CEFPODOXIME PROXETIL For Suspension; 50MG BASE/5ML VANTIN PHARMACIA AND UPJOHN 065082 CEFPODOXIME PROXETIL For Suspension; 100MG BASE/5ML CEFPODOXIME PROXETIL Ranbaxy 065082 CEFPODOXIME PROXETIL For Suspension; 50MG BASE/5ML CEFPODOXIME PROXETIL Ranbaxy 050674 CEFPODOXIME PROXETIL Tablet; 100MG BASE VANTIN PHARMACIA AND UPJOHN 050674 CEFPODOXIME PROXETIL Tablet; 200MG BASE VANTIN PHARMACIA AND UPJOHN 065083 CEFPODOXIME PROXETIL Tablet; 100MG BASE CEFPODOXIME PROXETIL Ranbaxy 065083 CEFPODOXIME PROXETIL Tablet; 200MG BASE CEFPODOXIME PROXETIL Ranbaxy Vantin (cefpodoxime proxetil) Oral Suspension, Pharmacia & Upjohn Vantin (cefpodoxime proxetil) Tablets, Pharmacia & Upjohn | Cefpodoxime Proxetil Oral Suspension, Aurobindo Pharma, Approval | Vantin (cefpodoxime proxetil) Tablets, Pfizer Pharma, Labeling Revision | Vantin (cefpodoxime proxetil) Oral Suspension, Pfizer Pharma, Labeling Revision | Cefpodoxime Proxetil Oral Suspension, Aurobindo Pharma, Approval | Cefpodoxime Proxetil Tablets, Aurobindo Pharma, Approval | Cefpodoxime Proxetil Tablets, Orchid Healthcare, Approval | Cefpodoxime Proxetil Tablets, Sandoz, Inc., Approval | Cefpodoxime Proxetil Oral Solution, Sandoz Inc., Approval
  
|